With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...

Was not going public a missed opportunity for the large analytics company or the key to preserving its identity?

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Morristown-based Sanofi will be the latest U.S. drugmaker to inject billions of dollars into domestic operations and American manufacturing.

Last week, it was announced that Genentech, a founding company in the biotech industry, plans to build a $700 million, ...